GlaxoSmithKline, which filled the seat of CEO-bound Emma Walmsley on Thursday, isn’t the only Big Pharma to tap a new consumer chief this week.

Regeneron is looking for ways to keep star med Eylea growing well into the future--and pacing ahead of the competition. But it looks like a combination with…

Hanmi Pharma gained one big deal with Roche this week, but lost another tie-up with Boehringer--and investors didn't like it one bit.

Vertex won a label expansion for cystic fibrosis combo Orkambi late Wednesday--but, as expected, the company lowered its full-year guidance for the med, too.…

Over 7 years, GlaxoSmithKline’s investment in Aspen Pharmacare grew in value sixfold. But that run has come to an end, as GSK wrapped up its final stake sale…

GlaxoSmithKline CEO-to-be Emma Walmsley will leave a chair vacant at the top of its key consumer health JV, and stepping in to take it is Brian McNamara, a…

Just two years after working on a massive dual-focus manufacturing facility in Asia, AbbVie says the first phase is good to go.

Teva, which already owns a solid dose plant in Russia, now has a sterile injectables facility. The new project comes even as the pharma is dealing with…